This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Seattle Children's Hospital, University of Cape Town. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 89 
1 out of 94 
Years Active: 2022
Title: Innovations of Adam Garth Penn-Nicholson
Introduction
Adam Garth Penn-Nicholson is a notable inventor based in Cape Town, South Africa. He has made significant contributions to the field of medical diagnostics, particularly in the area of tuberculosis (TB) risk assessment. His innovative work focuses on the development of biomarkers that can predict the progression of latent TB infection to active disease.
Latest Patents
Adam Garth Penn-Nicholson holds a patent for his invention titled "Biomarkers for prospective determination of risk for development of active tuberculosis." This invention relates to a prognostic method that quantifies and analyzes the relative abundances of pairs of gene products, known as TB biomarkers, derived from samples obtained from asymptomatic human subjects. The method aims to predict the likelihood of these individuals progressing to active tuberculosis disease. Additionally, the invention includes a kit comprising gene-specific primers or oligonucleotide probes for the detection of these biomarkers, facilitating the identification of individuals at risk. The invention also outlines a method for preventive treatment or prophylaxis for TB infection, utilizing the prognostic method and kit to select appropriate treatment regimes.
Career Highlights
Throughout his career, Adam has worked with esteemed institutions such as Seattle Children's Hospital and the University of Cape Town. His experience in these organizations has contributed to his expertise in medical research and innovation.
Collaborations
Adam has collaborated with notable professionals in his field, including Thomas Jens Scriba and Alan Arnold Aderem. These collaborations have further enhanced the impact of his work in tuberculosis research.
Conclusion
Adam Garth Penn-Nicholson's contributions to the field of tuberculosis diagnostics through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly improve the management and prevention of TB infection.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile